3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
9
Glioma
9
Osteosarcoma
8
Neuroblastoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Rhabdoid Tumor
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Central Nervous System Neoplasms
5
Carcinoma, Hepatocellular
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Interventions
ruxolitinib
13
Cyclophosphamide
5
Tacrolimus
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Stem Cell Transplantation
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclosporine
3
fludarabine
2
fedratinib
2
Sirolimus
2
Injections
2
Busulfan
2
Biopsy
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
veliparib
1
umbralisib
1
thymoglobulin
1
selinexor
1
reparixin
1
piperine
1
pegylated granulocyte colony-stimulating factor
1
navitoclax
1
luspatercept
1
letermovir
1
itacitinib
1
iadademstat
1
demethoxycurcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
X-Rays
×
90 days
×
Clear all
No trials found.